IAPP and neurodegenerative disease: In contrast, a secondary nucleation mechanism has been inferred in cases involved in the amyloid formation of peptides and proteins associated with neurodegenerative diseases and type 2 diabetes (e.g., Aβ42, Aβ40, a-synuclein, IAPP, and insulin; reviewed in ref. 53).